Evidence that MIG-6 is a tumor-suppressor gene

被引:0
|
作者
Y-W Zhang
B Staal
Y Su
P Swiatek
P Zhao
B Cao
J Resau
R Sigler
R Bronson
G F Vande Woude
机构
[1] Laboratory of Molecular Oncology,Division of Pfizer
[2] Van Andel Research Institute,Department of Pathology
[3] Laboratory of Germline Modification,undefined
[4] Van Andel Research Institute,undefined
[5] Laboratory of Antibody Technology,undefined
[6] Van Andel Research Institute,undefined
[7] Laboratory of Analytical,undefined
[8] Cellular,undefined
[9] and Molecular Microscopy,undefined
[10] Van Andel Research Institute,undefined
[11] Esperion Therapeutics,undefined
[12] Harvard Medical School,undefined
来源
Oncogene | 2007年 / 26卷
关键词
MIG-6; mutation; lung carcinogenesis; signal transduction; EGF; HGF/SF;
D O I
暂无
中图分类号
学科分类号
摘要
Mitogen-inducible gene 6 (MIG-6) is located in human chromosome 1p36, a locus frequently associated with human lung cancer. MIG-6 is a negative regulator of epidermal growth factor (EGF) signaling, and we show that Mig-6 – like EGF – is induced by hepatocyte growth factor/scatter factor (HGF/SF) in human lung cancer cell lines. Frequently, the receptors for both factors, EGFR and Met, are expressed in same lung cancer cell line, and MIG-6 is induced by both factors in a mitogen-activated protein kinase-dependent fashion. However, not all tumor lines express MIG-6 in response to either EGF or HGF/SF. In these cases, we find missense and nonsense mutations in the MIG-6 coding region, as well as evidence for MIG-6 transcriptional silencing. Moreover, germline disruption of Mig-6 in mice leads to the development of animals with epithelial hyperplasia, adenoma, and adenocarcinoma in organs like the lung, gallbladder, and bile duct. These data suggests that MIG-6 is a tumor-suppressor gene and is therefore a candidate gene for the frequent 1p36 genetic alterations found in lung cancer.
引用
收藏
页码:269 / 276
页数:7
相关论文
共 50 条
  • [31] IDENTIFICATION OF A NOVEL TUMOR-SUPPRESSOR GENE IN BARRETTS CANCER
    WRIGHT, TA
    SWIFT, A
    KINGSNORTH, AN
    FIELD, JK
    BRITISH JOURNAL OF SURGERY, 1995, 82 (05) : 702 - 702
  • [32] THE FUNCTIONS OF THE P53 TUMOR-SUPPRESSOR GENE
    LEVINE, AJ
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 5 - 5
  • [33] The retinoblastoma tumor-suppressor gene, the exception that proves the rule
    D W Goodrich
    Oncogene, 2006, 25 : 5233 - 5243
  • [34] Translational Advances in Oncogene and Tumor-Suppressor Gene Research
    Stojchevski, Radoslav
    Sutanto, Edward Agus
    Sutanto, Rinni
    Hadzi-Petrushev, Nikola
    Mladenov, Mitko
    Singh, Sajal Raj
    Sinha, Jitendra Kumar
    Ghosh, Shampa
    Yarlagadda, Bhuvaneshwar
    Singh, Krishna Kumar
    Verma, Prashant
    Sengupta, Sonali
    Bhaskar, Rakesh
    Avtanski, Dimiter
    CANCERS, 2025, 17 (06)
  • [35] EXPRESSION OF THE TUMOR-SUPPRESSOR GENE DCC IN HUMAN GLIOMAS
    SCHECK, AC
    COONS, SW
    CANCER RESEARCH, 1993, 53 (23) : 5605 - 5609
  • [36] ADENOVIRUS E1A AS A TUMOR-SUPPRESSOR GENE
    CHINNADURAI, G
    ONCOGENE, 1992, 7 (07) : 1255 - 1258
  • [37] Generation of a Mig-6 conditional null allele
    Jin, Nili
    Gilbert, Jennifer L.
    Broaddus, Russell R.
    DeMayo, Francesco J.
    Jeong, Jae-Wook
    GENESIS, 2007, 45 (11) : 716 - 721
  • [38] TUMOR-SUPPRESSOR GENES
    HINDS, PW
    WEINBERG, RA
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 1994, 4 (01) : 135 - 141
  • [39] Absence of mutation in the putative tumor-suppressor gene KLF6 in colorectal cancers
    Astrid Lièvre
    Bruno Landi
    Jean-François Côté
    Nicolas Veyrie
    Jessica Zucman-Rossi
    Anne Berger
    Pierre Laurent-Puig
    Oncogene, 2005, 24 : 7253 - 7256
  • [40] THE TUMOR-SUPPRESSOR GENES
    LEVINE, AJ
    ANNUAL REVIEW OF BIOCHEMISTRY, 1993, 62 : 623 - 651